Theravance Biopharma, Inc. (TBPH)
16.25
+0.03
(+0.18%)
USD |
NASDAQ |
May 18, 15:02
Theravance Biopharma Shareholders Equity (Quarterly) : 290.59M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 14.66B |
| Relmada Therapeutics, Inc. | 218.73M |
| Indivior Pharmaceuticals, Inc. | -144.00M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 472.31M |
| Total Liabilities (Quarterly) | 181.72M |
| Debt to Equity Ratio | 0.2522 |
| Current Ratio | 13.14 |
| Net Debt Paydown Yield | -0.56% |